AdvanSix (NYSE:ASIX) Trading Up 3.4% – What’s Next?

AdvanSix Inc. (NYSE:ASIX)’s stock price was up 3.4% on Monday . The stock traded as high as $32.73 and last traded at $32.55. Approximately 22,791 shares traded hands during trading, a decline of 84% from the average daily volume of 140,259 shares. The stock had previously closed at $31.48.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on ASIX shares. Piper Sandler upped their price target on shares of AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, November 8th. StockNews.com raised shares of AdvanSix from a “hold” rating to a “buy” rating in a research report on Wednesday, December 4th.

AdvanSix Price Performance

The company has a market capitalization of $843.33 million, a PE ratio of 22.38 and a beta of 1.73. The firm has a fifty day simple moving average of $30.56 and a 200 day simple moving average of $27.72. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.62 and a current ratio of 1.34.

AdvanSix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were issued a $0.16 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.64 annualized dividend and a dividend yield of 2.03%. AdvanSix’s payout ratio is currently 45.39%.

Insider Transactions at AdvanSix

In related news, insider Christopher Gramm sold 2,435 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $32.00, for a total transaction of $77,920.00. Following the completion of the transaction, the insider now owns 43,463 shares in the company, valued at $1,390,816. The trade was a 5.31 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Erin N. Kane sold 5,000 shares of the firm’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $30.37, for a total value of $151,850.00. Following the completion of the sale, the chief executive officer now directly owns 517,795 shares of the company’s stock, valued at $15,725,434.15. The trade was a 0.96 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,369 shares of company stock valued at $474,058. Company insiders own 5.60% of the company’s stock.

Institutional Trading of AdvanSix

Several large investors have recently added to or reduced their stakes in the company. Point72 DIFC Ltd acquired a new stake in AdvanSix during the 2nd quarter valued at approximately $34,000. Acadian Asset Management LLC purchased a new stake in shares of AdvanSix in the second quarter valued at approximately $36,000. Copeland Capital Management LLC acquired a new position in AdvanSix during the third quarter worth $41,000. Allspring Global Investments Holdings LLC acquired a new position in shares of AdvanSix during the 2nd quarter worth about $51,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of AdvanSix in the second quarter valued at approximately $51,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.

AdvanSix Company Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.